Original articles
The role of SIGLEC9 in immunosuppression and prognosis in cervical cancer
Bihui Wanga,b, Yuejie Zhuc, Zhenyu Rud, Yulian Zhanga,b, Mingkai Yue, Pingfen Lif, Manli Zhangc, Jianbing Dingg, Zhifang Chena,b,
Corresponding author
645286940@qq.com
Corresponding author at: Department of Gynecology, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Corresponding author at: Department of Gynecology, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
a Department of Gynecology, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
b State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
c Center for Reproductive Medicine, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
d Department of Gastroenterology, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
e School of Life Science and Technology, Southeast University, Nanjing, China
f Department of Reproductive Medicine, The First Affiliated Hospital of Xi'an Jiao Tong University, Shanxi, Xi’an, China
g Department of Immunology, College of Basic Medicine of Xinjiang Medical University, Urumqi, China